Novel combined glucose-lowering drug with DPP-4 inhibitor and pioglitazone
Fujita, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 642-646
2012
ISSN/ISBN: 0047-1852 PMID: 22768591 Document Number: 659741
Document emailed within 1 workday
Related Documents
Okada, S.; Ishii, K.; Tanokuchi, S.; Hamada, H.; Ichiki, K.; Ota, Z. 1995: Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus Journal of International Medical Research 23(4): 279-283Sugiyama, Y.; Taketomi, S.; Shimura, Y.; Ikeda, H.; Fujita, T. 1990: Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats Arzneimittel-Forschung 40(3): 263-267
Karim, M.R.; Ahmed, H.; Paul, R.K.; Chowdhury, M.; Alam, M.S.; Saha, A. 2016: Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients Mymensingh Medical Journal: Mmj 25(2): 198-204
Traber, D.L.; Adams, T.; Sziebert, L.; Williams, P.; Traber, L.D. 1984: Failure of a protease inhibitor to affect the cardiopulmonary response to endotoxin when combined with a cyclooxygenase inhibitor Circulatory Shock 13(4): 319-323
Scheen, A.J. 2012: Use of oral glucose-lowering agents in patients with renal impairment Revue Medicale Suisse 8(351): 1614-1620
Budenholzer, B. 2001: Glycaemia and vascular effects of type 2 diabetes. Lowering glucose concentrations may not be of any value in itself Bmj 322(7296): 1245-6; Author Reply 1247
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816
Haupt, E.; Laube, F.; Loy, H.; Schöffling, K. 1977: Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides Medizinische Klinik 72(38): 1529-1536
Hoppichler, F.; Lechleitner, M.; Patsch, J.R. 1992: Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(11): 523-527
Tharavanij, T.; Pawa, K.K.; Maungboon, P.; Panpitpat, P.; Porntisan, S.; Thangcharoende, W.; Tasanarong, A.; Ritthidej, G.C.; Jesadanont, S. 2015: Glucose-Lowering Efficacy of Water Extract of Malvastrum coromandelianum in Type 2 Diabetes Subjects: a Double Blind, Randomized Controlled Trial Journal of the Medical Association of Thailand 98(Suppl 3): S75-S80
Fu, J.; Tang, H-Qin.; Qin, X-Hui.; Mao, G-Yun.; Tang, G-Fu. 2009: Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level Zhonghua Yi Xue Za Zhi 89(31): 2179-2183
Verburg, A.F.E.; van den Donk, M.; Wiersma, T. 2019: Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors Nederlands Tijdschrift Voor Geneeskunde 163
Roubsanthisuk, W.; Watanakejorn, P.; Tunlakit, M.; Sriussadaporn, S. 2006: Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity Journal of the Medical Association of Thailand 89(Suppl 5): S133-S140
Potì, R.; Quintavalla, R.; Manotti, C. 1977: Clinical experimentation with a new drug lowering blood lipids (Tiadenol) Giornale di Clinica Medica 58(7-8): 293-300
Nishimura, R. 2012: Efficacy of DPP-4 inhibitor evaluated by CGM (continuous glucose monitoring) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(11): 2023-2029
Mori, Y. 2011: Efficacy of a DPP-4 inhibitor as assessed by continuous glucose monitoring (CGM) Nihon Rinsho. Japanese Journal of Clinical Medicine 69(5): 912-917
Pike, N.B.; Wise, A. 2004: Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug? Current Opinion in Investigational Drugs 5(3): 271-275
Mamedov, M.N.; Perova, N.V.; Kosmatova, O.V.; Khadipash, L.A.; Kiseleva, N.V.; Oganov, R.G. 2003: Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome Kardiologiia 43(3): 13-19
Fisker, F.; Møller, N.; Lauritzen, E.S. 2019: Sodium-glucose-cotransporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis Ugeskrift for Laeger 181(21)
Lutz-Ostertag, Y. 1977: The combined effects of testosterone propionate and a temporary lowering of temperature on the fate of Müllerian ducts of the female bird embryo. Morphological, histological, and cytobiochemical studies Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 171(4): 778-783